Brief: CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO
20/10/2025 14:07
Oct 20 (Reuters) - Redhill Biopharma Ltd 2RHy.F: CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO Source text: ID:nPnbntmspa Further company coverage: [2RHy.F] ((Reuters.Briefs@thomsonreuters.com;))